Literature DB >> 31509823

Chinese Expert Recommendation for Diagnosis and Treatment of Massive Hemoptysis.

Faguang Jin1, Qiang Li2, Chong Bai3, Hongwu Wang4, Shiyue Li5, Yong Song6, Yiming Zeng7, Rui Zhou8, Wangping Li9, Chengping Hu10, Jie Zhang11, Hongmei Zhou12, Haitao Zhang9.   

Abstract

Massive hemoptysis is one of emergency and critical diseases of the respiratory system. The definition of massive hemoptysis has always been different in the literature, which often depends on the quantitative estimation of the amount of hemoptysis, such as the amount of hemoptysis being in the range of 300-600 mL within 24 h, or hemoptysis more than 3 times within 1 week. Each amount of hemoptysis that is greater than 100 mL can be considered as massive hemoptysis, but the amount of hemoptysis is difficult to accurately estimate. Therefore, massive hemoptysis can be defined as any life-threatening hemoptysis and any hemoptysis that may cause airway obstruction and asphyxia. Massive hemoptysis accounts for approximately 5% of all hemoptysis cases and usually indicates the presence of a potentially severe respiratory or systemic disease. The mortality rate of massive hemoptysis is about 6.5-38%. The cause of death is generally shock caused by airway obstruction or excessive bleeding, and asphyxia is the main cause of death. At present, due to insufficient understanding of massive hemoptysis, there are limited technical means in the etiological diagnosis and untimely or improper treatment, resulting in high mortality of massive hemoptysis. Therefore, the diagnosis and treatment of massive hemoptysis needs to be standardized.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  China; Guidelines; Massive hemoptysis

Mesh:

Year:  2019        PMID: 31509823     DOI: 10.1159/000502156

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  A case of massive hemoptysis after radiofrequency catheter ablation for atrial fibrillation.

Authors:  Zhen Ren; Shu Li; Qing-Bian Ma
Journal:  World J Emerg Med       Date:  2022

2.  A retrospective analysis of risk factors for massive hemoptysis in patients with bronchiectasis.

Authors:  Ling Luo; Jing Luo; Yu Jiang
Journal:  BMC Pulm Med       Date:  2022-06-02       Impact factor: 3.320

3.  Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report.

Authors:  Tae-Ok Kim; Min-Suk Kim; Bo Gun Kho; Ha Young Park; Yong-Soo Kwon; Yu-Il Kim; Sung-Chul Lim; Hong-Joon Shin
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

4.  Emergency pulmonary resection in massive hemoptysis: analysis of 39 patients.

Authors:  Serkan Yazgan; Ahmet Ucvet; Kenan Can Ceylan; Canberk Heskiloglu; Banu Yoldas; Serpil Sevinc
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-01-09

5.  Outcomes of bronchial artery embolization for the management of hemoptysis.

Authors:  Narjes Abid; Manel Loukil; Amani Mokni; Imen Badri; Khaled Bouzaidi; Hedia Ghrairi
Journal:  Tunis Med       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.